RL-6A

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRL-6A
Drug Alias NameHLA antigen modulator (Receptor Logic)T-cell receptor mimic mAbs (Receptor Logic)RL-6A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionHuman leukocyte antigen modulators
TargetsHuman leukocyte antigen
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReceptor Logic Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReceptor Logic Inc
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A